Literature DB >> 12239167

Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartment.

Eduardo Davila1, Maria G Velez, Carrie J Heppelmann, Esteban Celis.   

Abstract

Many of the mechanisms that govern T-cell homeostasis remain obscure. Here we report that repeated administration of synthetic oligodeoxynucleotides containing unmethylated cytosine-guanine motifs (CpG-ODN) into mice induces a systemic antigen-independent expansion of naive and memory T cells in a full T-cell compartment. Expansion of T cells was observed on both CD4(+) and CD8(+) T-cell subsets and was produced not by inducing the proliferation of the cells but by preventing their death. The antiapoptotic effects of CpG-ODN on T cells were observed against activation-induced death and growth factor withdrawal-mediated death. The ability of CpG-ODN to protect T cells from these forms of death was associated with the up-regulation of antiapoptotic gene products including c-FLIP, bcl-xL, and, to some extent, bcl-2. The effect of CpG-ODN on naive and memory T cells required the expression of CD28 and was not dependent on the presence of B lymphocytes, suggesting that other antigen-presenting cells that respond to CpG-ODN, such as dendritic cells, may provide antiapoptotic signals to T cells in an antigen-independent but CD28/B7-dependent fashion. The present findings suggest that CpG-ODN can disrupt normal T-cell homeostasis not by acting as a mitogen but by preventing T-cell death that normally takes place as a mechanism to maintain steady-state levels of T cells. These findings support a potential means to expeditiously replenish and maintain the peripheral lymphocyte population after severe immunodepletion such as that which occurs in HIV-infected individuals and individuals undergoing cytoablative therapies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12239167     DOI: 10.1182/blood-2002-02-0401

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse.

Authors:  Nadira Durakovic; Vedran Radojcic; Mario Skarica; Karl B Bezak; Jonathan D Powell; Ephraim J Fuchs; Leo Luznik
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

2.  CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.

Authors:  Janina Q Jiang; Amy Patrick; Ronald B Moss; Kenneth L Rosenthal
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in NC/Nga mice.

Authors:  Joe Inoue; Satoshi Yotsumoto; Takatoshi Sakamoto; Seishi Tsuchiya; Yukihiko Aramaki
Journal:  Pharm Res       Date:  2005-09-26       Impact factor: 4.200

Review 4.  Effects of Toll-like receptor signals in T-cell neoplasms.

Authors:  Cori Morrison; Maria R Baer; Dan P Zandberg; Amy Kimball; Eduardo Davila
Journal:  Future Oncol       Date:  2011-02       Impact factor: 3.404

5.  Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of CD8+ cells, interferon-gamma recovery and reduction of lung injury.

Authors:  V L D Bonato; E D C Gonçalves; E G Soares; R R Santos Júnior; A Sartori; A A M Coelho-Castelo; C L Silva
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

6.  Inducible nitric oxide synthase in T cells regulates T cell death and immune memory.

Authors:  Monika Vig; Smita Srivastava; Usha Kandpal; Hadassah Sade; Virginia Lewis; Apurva Sarin; Anna George; Vineeta Bal; Jeannine M Durdik; Satyajit Rath
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

7.  Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors.

Authors:  Pilar Nava-Parada; Guido Forni; Keith L Knutson; Larry R Pease; Esteban Celis
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

8.  Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity.

Authors:  Nicole Asprodites; Liqin Zheng; Degui Geng; Cruz Velasco-Gonzalez; Luis Sanchez-Perez; Eduardo Davila
Journal:  FASEB J       Date:  2008-06-27       Impact factor: 5.191

9.  Antigen-free adjuvant assists late effector CD4 T cells to transit to memory in lymphopenic hosts.

Authors:  F Betul Guloglu; Jason S Ellis; Xiaoxiao Wan; Mermagya Dhakal; Christine M Hoeman; Jason A Cascio; Habib Zaghouani
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

Review 10.  Immune deficits in allogeneic hematopoietic stem cell transplant (HSCT) recipients.

Authors:  Muhammad A Mir; Minoo Battiwalla
Journal:  Mycopathologia       Date:  2009-01-21       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.